There were significantly lower occurrence of both IgG (11%, p = 0.03, Fig. 2C) and IgM (10%, p < 0.01, Fig. 2D) anti-cardiac autoantibodies in patients with advanced aortic stenosis undergoing trans-catheter valve replacement therapy. This evidence concerns the gene CD40LG and aortic stenosis.